Patents by Inventor Alan Nimmo

Alan Nimmo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF TREATMENT AND/OR PREVENTION OF BRAIN, SPINAL OR NERVE INJURY
    Publication number: 20110053954
    Abstract: The invention relates to a method of treatment and/or prevention of brain, spinal or nerve injury comprising administration to a person in need of such treatment, of a therapeutically effective amount of an NK-1 receptor antagonist compound of the formula wherein the meanings of R, R1, R2, R2?, R3, and R4 are explained in the specification and the pharmaceutically acceptable acid addition salts and the prodrugs thereof either alone or in combination with a magnesium salt. Exemplified is the use of N-(3,5-bis-trifluoromethyl-benzyl)-N-methyl-6-(4-methyl-piperazin-1-yl)-4-o-tolyl-nicotinamide. The invention also relates to pharmaceutical composition comprising one or more such NK-1 receptor antagonists, optionally in combination with a magnesium salt, and a pharmaceutically acceptable excipient for the treatment and/or prevention of brain, spinal or nerve injury.
    Type: Application
    Filed: September 21, 2010
    Publication date: March 3, 2011
    Inventors: Torsten Hoffmann, Alan Nimmo, Andrew Sleight, Pierre Vankan, Robert Vink
  • Method of treatment and/or prevention of brain, spinal or nerve injury
    Publication number: 20060247240
    Abstract: The invention relates to a method of treatment and/or prevention of brain, spinal or nerve injury comprising administration to a person in need of such treatment, of a therapeutically effective amount of an NK-1 receptor antagonist compound of the formula wherein the meanings of R, R1, R2, R2, R3, and R4 are explained in the specification and the pharmaceutically acceptable acid addition salts and the prodrugs thereof either alone or in combination with a magnesium salt. Exemplified is the use of N-(3,5-bis-trifluoromethyl-benzyl)-N-methyl-6-(4-methyl-piperazin-1-yl)-4-o-tolyl-nicotinamide. The invention also relates to pharmaceutical composition comprising one or more such NK-1 receptor antagonists, optionally in combination with a magnesium salt, and a pharmaceutically acceptable excipient for the treatment and/or prevention of brain, spinal or nerve injury.
    Type: Application
    Filed: July 5, 2006
    Publication date: November 2, 2006
    Inventors: Torsten Hoffmann, Alan Nimmo, Andrew Sleight, Pierre Vankan, Robert Vink
  • Brain, spinal and nerve injury treatment
    Publication number: 20050107380
    Abstract: A treatment for brain, spinal and nerve injury comprising use of a substance P receptor antagonist optionally in combination with a magnesium compound. There is also provided a formulation for use in this treatment comprising a substance P receptor antagonist and a magnesium compound.
    Type: Application
    Filed: December 21, 2004
    Publication date: May 19, 2005
    Inventors: Alan Nimmo, Robert Vink
  • Method of treatment and/or prevention of brain, spinal or nerve injury
    Publication number: 20030083345
    Abstract: The invention relates to a method of treatment and/or prevention of brain, spinal or nerve injury comprising administration to a person in need of such treatment, of a therapeutically effective amount of an NK-1 receptor antagonist compound of the formula 1
    Type: Application
    Filed: July 2, 2002
    Publication date: May 1, 2003
    Inventors: Torsten Hoffmann, Alan Nimmo, Andrew Sleight, Pierre Vankan, Robert Vink